Initiating anticoagulant therapy after ICH is associated with patient characteristics and treatment recommendations

被引:14
作者
Sembill, Jochen A. [1 ]
Wieser, Claudia Y. [1 ]
Spruegel, Maximilian I. [1 ]
Gerner, Stefan T. [1 ]
Giede-Jeppe, Antje [1 ]
Reindl, Caroline [1 ]
Eyuepoglu, Ilker Y. [2 ]
Hoelter, Philip [3 ]
Luecking, Hannes [3 ]
Kuramatsu, Joji B. [1 ]
Huttner, Hagen B. [1 ]
机构
[1] Univ Erlangen Nurnberg, Dept Neurol, Schwabachanlage 6, D-91054 Erlangen, Germany
[2] Univ Erlangen Nurnberg, Dept Neurosurg, Schwabachanlage 6, D-91054 Erlangen, Germany
[3] Univ Erlangen Nurnberg, Dept Neuroradiol, Schwabachanlage 6, D-91054 Erlangen, Germany
关键词
Cerebral hemorrhage; Stroke prevention; Anticoagulant therapy; SPONTANEOUS INTRACEREBRAL HEMORRHAGE; ATRIAL-FIBRILLATION; INTRACRANIAL HEMORRHAGE; RECURRENT STROKE; RISK; GUIDELINES; MANAGEMENT; COHORT; SCORE;
D O I
10.1007/s00415-018-9009-2
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The proportion of patients with intracerebral hemorrhage (ICH) and concomitant indication for oral anticoagulant (OAC) therapy is increasing. Although recent studies documented a favorable risk-benefit profile of OAC initiation, deciding whether, when, and which OAC should be started remains controversial. We investigated (1) OAC recommendations, its implementation, and adherence and (2) factors associated with OAC initiation after ICH. This prospective observational study analyzed consecutive ICH patients (n = 246) treated at the neurological and neurosurgical department of the University-Hospital Erlangen, Germany over a 21-month inclusion period (05/2013-01/2015). We analyzed the influence of patient characteristics, in-hospital measures, and functional status on treatment recommendations and on OAC initiation during 12-month follow-up. In-hospital mortality of 24.8% (n = 61/246) left 185 patients discharged alive of which 34.1% (n = 63/185) had OAC indication. In these patients, OAC initiation was clearly recommended in only 49.2% (n = 31/63) and associated with favorable [modified Rankin Scale (mRS) = 0-3] functional discharge status [OR 7.18, CI (1.05-49.13), p = 0.04], less frequent heart failure [OR 0.19, CI (0.05-0.71), p = 0.01], and younger age [OR 0.95, CI (0.90-1.00), p = 0.05]. OAC was more often started if clearly recommended [n = 19/31 (61.3%) versus (no recommendation) n = 4/26 (15.4%), p < 0.001; (clearly not recommended, n = 6)] and associated with younger age [67 (58-74) versus 79 (73-83), p < 0.001], favorable functional outcome [n = 10/23 (43.5%) versus n = 5/40 (12.5%), p = 0.01], decreased mortality [n = 6/23 (26.1%) versus n = 19/40 (47.5%), p = 0.06], and functional improvement [n = 13/17 (76.5%) versus n = 7/21 (33.3%), p = 0.01]. We observed no differences in rates of intracranial complications [thromboembolism, n = 3/23 (13.0%) versus n = 4/40 (10.0%), p = 1.00; hemorrhage, n = 1/23 (4.3%) versus n = 3/40 (7.5%), p = 1.00]. Clear treatment recommendations by attending stroke physicians significantly influence OAC initiation after ICH. OAC were more frequently recommended and started in younger patients with better functional recovery independent from intracranial complications. This might represent an important determinant of observed beneficial associations, hinting towards an indication bias which might affect observational analyses.
引用
收藏
页码:2404 / 2414
页数:11
相关论文
共 25 条
[1]   Oral Anticoagulation and Functional Outcome after Intracerebral Hemorrhage [J].
Biffi, Alessandro ;
Kuramatsu, Joji B. ;
Leasure, Audrey ;
Kamel, Hooman ;
Kourkoulis, Christina ;
Schwab, Kristin ;
Ayres, Alison M. ;
Elm, Jordan ;
Gurol, M. Edip ;
Greenberg, Steven M. ;
Viswanathan, Anand ;
Anderson, Christopher D. ;
Schwab, Stefan ;
Rosand, Jonathan ;
Testai, Fernando D. ;
Woo, Daniel ;
Huttner, Hagen B. ;
Sheth, Kevin N. .
ANNALS OF NEUROLOGY, 2017, 82 (05) :755-765
[2]   New Oral Anticoagulants and the Risk of Intracranial Hemorrhage Traditional and Bayesian Meta-analysis and Mixed Treatment Comparison of Randomized Trials of New Oral Anticoagulants in Atrial Fibrillation [J].
Chatterjee, Saurav ;
Sardar, Partha ;
Biondi-Zoccai, Giuseppe ;
Kumbhani, Dharam J. .
JAMA NEUROLOGY, 2013, 70 (12) :1486-1490
[3]   Should anticoagulation be resumed after intracerebral hemorrhage? [J].
Goldstein, Joshua N. ;
Greenberg, Steven M. .
CLEVELAND CLINIC JOURNAL OF MEDICINE, 2010, 77 (11) :791-799
[4]   Anticoagulation in Patients With Atrial Fibrillation in the Setting of Prior Hemorrhage An Ongoing Dilemma [J].
Goldstein, Larry B. .
STROKE, 2017, 48 (10) :2654-2659
[5]   Reasons Underlying Non-Adherence to and Discontinuation of Anticoagulation in Secondary Stroke Prevention among Patients with Atrial Fibrillation [J].
Gumbinger, Christoph ;
Holstein, Timo ;
Stock, Christian ;
Rizos, Timolaos ;
Horstmann, Solveig ;
Veltkamp, Roland .
EUROPEAN NEUROLOGY, 2015, 73 (3-4) :184-191
[6]   Guidelines for the Management of Spontaneous Intracerebral Hemorrhage A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association [J].
Hemphill, J. Claude, III ;
Greenberg, Steven M. ;
Anderson, Craig S. ;
Becker, Kyra ;
Bendok, Bernard R. ;
Cushman, Mary ;
Fung, Gordon L. ;
Goldstein, Joshua N. ;
Macdonald, R. Loch ;
Mitchell, Pamela H. ;
Scott, Phillip A. ;
Selim, Magdy H. ;
Woo, Daniel .
STROKE, 2015, 46 (07) :2032-2060
[7]   Anticoagulation Use and Clinical Outcomes After Major Bleeding on Dabigatran or Warfarin in Atrial Fibrillation [J].
Hernandez, Inmaculada ;
Zhang, Yuting ;
Brooks, Maria M. ;
Chin, Paul K. L. ;
Saba, Samir .
STROKE, 2017, 48 (01) :159-+
[8]   Prevalence of atrial fibrillation in intracerebral hemorrhage [J].
Horstmann, S. ;
Rizos, T. ;
Jenetzky, E. ;
Gumbinger, C. ;
Hacke, W. ;
Veltkamp, R. .
EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 (04) :570-576
[9]   Characterization of patients with atrial fibrillation not treated with oral anticoagulants [J].
Johansson, Cecilia ;
Hagg, Lovisa ;
Johansson, Lars ;
Jansson, Jan-Hakan .
SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE, 2014, 32 (04) :226-231
[10]   Management of therapeutic anticoagulation in patients with intracerebral haemorrhage andmechanical heart valves [J].
Kuramatsu, Joji B. ;
Sembill, Jochen A. ;
Gerner, Stefan T. ;
Spruegel, Maximilian I. ;
Hagen, Manuel ;
Roeder, Sebastian S. ;
Endres, Matthias ;
Haeusler, Karl Georg ;
Sobesky, Jan ;
Schurig, Johannes ;
Zweynert, Sarah ;
Bauer, Miriam ;
Vajkoczy, Peter ;
Ringleb, Peter A. ;
Purrucker, Jan ;
Rizos, Timolaos ;
Volkmann, Jens ;
Muellges, Wolfgang ;
Kraft, Peter ;
Schubert, Anna-Lena ;
Erbguth, Frank ;
Nueckel, Martin ;
Schellinger, Peter D. ;
Glahn, Joerg ;
Knappe, Ulrich J. ;
Fink, Gereon R. ;
Dohmen, Christian ;
Stetefeld, Henning ;
Fisse, Anna Lena ;
Minnerup, Jens ;
Hagemann, Georg ;
Rakers, Florian ;
Reichmann, Heinz ;
Schneider, Hauke ;
Woepking, Sigrid ;
Ludolph, Albert Christian ;
Stoesser, Sebastian ;
Neugebauer, Hermann ;
Roether, Joachim ;
Michels, Peter ;
Schwarz, Michael ;
Reimann, Gernot ;
Baezner, Hansjoerg ;
Schwert, Henning ;
Classen, Joseph ;
Michalski, Dominik ;
Grau, Armin ;
Palm, Frederick ;
Urbanek, Christian ;
Woehrle, Johannes C. .
EUROPEAN HEART JOURNAL, 2018, 39 (19) :1709-1723